Another study by Richer et al. demonstrated that AR inhibitor Enzalutamide inhibited DHT- driven MCF-7 cells proliferation in vitro as well as tumor growth in both ER+ (MCF7) and ER- (MDA-MB-453) xenografts [40]. This evidence concerns the gene AR and neoplasm.